Anish John

2022

In 2022, Anish John earned a total compensation of $738.2K as Chief Financial Officer at Oncocyte Corp.

Compensation breakdown

Bonus$98,835
Option Awards$189,606
Salary$285,962
Stock Awards$145,500
Other$18,259
Total$738,162

John received $286K in salary, accounting for 39% of the total pay in 2022.

John also received $98.8K in bonus, $189.6K in option awards, $145.5K in stock awards and $18.3K in other compensation.

Rankings

In 2022, Anish John's compensation ranked 3,660th out of 5,736 executives tracked by ExecPay. In other words, John earned more than 36.2% of executives.

ClassificationRankingPercentile
All
3,660
out of 5,736
36th
Division
Manufacturing
2,081
out of 3,125
33rd
Major group
Chemicals And Allied Products
1,002
out of 1,416
29th
Industry group
Drugs
939
out of 1,317
29th
Industry
In Vitro and In Vivo Diagnostic Substances
15
out of 29
48th
Source: SEC filing on May 19, 2023.

John's colleagues

We found five more compensation records of executives who worked with Anish John at Oncocyte Corp in 2022.

2022

Ronald Andrews

Oncocyte Corp

Chief Executive Officer

2022

Gisela Paulsen

Oncocyte Corp

Chief Operating Officer

2022

Douglas Ross

Oncocyte Corp

Chief Scientific Officer

2022

Joshua Riggs

Oncocyte Corp

Chief Executive Officer

2022

James Liu

Oncocyte Corp

Controller and Principal Accounting Officer

News

You may also like